Edition:
United Kingdom

PAVmed Inc (PAVM.OQ)

PAVM.OQ on NASDAQ Stock Exchange Capital Market

2.45USD
15 Dec 2017
Change (% chg)

$-0.29 (-10.58%)
Prev Close
$2.74
Open
$2.65
Day's High
$2.79
Day's Low
$2.45
Volume
6,018
Avg. Vol
4,521
52-wk High
$9.25
52-wk Low
$2.45

Latest Key Developments (Source: Significant Developments)

Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Pavmed Inc ::PAVMED FILES 510(K) SUBMISSION WITH FDA FOR CARPX™ DEVICE TO TREAT CARPAL TUNNEL SYNDROME.PAVMED INC - ‍TARGETING CLEARANCE FOR 510(K) PREMARKET NOTIFICATION SUBMISSION FOR CARPX DEVICE IN FIRST HALF OF 2018​.  Full Article

Pavmed reports Q3 adjusted non-GAAP loss per share $0.13
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Pavmed Inc :Pavmed reports third quarter 2017 financial results.Q3 GAAP loss per share $0.40.Q3 adjusted non-GAAP loss per share $0.13.  Full Article

Pavmed offers up to 2.7 mln shares
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Pavmed Inc ::Pavmed files for offering of up to 2.7 million shares of co that may be offered for resale by selling stockholders - SEC filing.  Full Article

Pavmed reports Q2 results; provides update on carpX device
Tuesday, 16 Aug 2016 

PAVmed Inc : PAVmed Inc announces second quarter 2016 financial results and provides business update . Now initiated final design phase for commercial carpX device .To initiate formal verification, validation testing for commercial carpX device by end of year & submit 510(K) application to FDA in 2017.  Full Article

PAVmed sets Q4 timeline for FDA submission of first product
Thursday, 14 Jul 2016 

PAVmed Inc : PAVmed sets Q4 2016 timeline for FDA submission of its first product . Says it has set a Q4 2016 timeline for FDA 510(K) submission of its first product, Portio(tm) implantable vascular access device .Says looks forward to following the submission with additional product submissions and commercialization in 2017.  Full Article

BRIEF-Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome

* PAVMED FILES 510(K) SUBMISSION WITH FDA FOR CARPX™ DEVICE TO TREAT CARPAL TUNNEL SYNDROME